Michael Dehn - Net Worth and Insider Trading
Michael Dehn Net Worth
The estimated net worth of Michael Dehn is at least $4 Million dollars as of 2024-11-13. Michael Dehn is the Director, Senior Officer of Knight Therapeutics Inc and owns about 759,523 shares of Knight Therapeutics Inc (TSX:GUD) stock worth over $4 Million. Michael Dehn is also the Director, Senior Officer of Temas Resources Corp and owns about 495,000 shares of Temas Resources Corp (XCNQ:TMAS) stock worth over $47,025. Details can be seen in Michael Dehn's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael Dehn has not made any transactions after 2021-12-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael Dehn
Michael Dehn Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael Dehn owns 2 companies in total, including Knight Therapeutics Inc (TSX:GUD) , and Temas Resources Corp (XCNQ:TMAS) .
Click here to see the complete history of Michael Dehn’s form 4 insider trades.
Insider Ownership Summary of Michael Dehn
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSX:GUD | Knight Therapeutics Inc | 2019-08-12 | Director & Senior Officer |
| XCNQ:TMAS | Temas Resources Corp | 2021-12-23 | Director & Senior Officer |
Michael Dehn Latest Holdings Summary
Michael Dehn currently owns a total of 2 stocks. Among these stocks, Michael Dehn owns 759,523 shares of Knight Therapeutics Inc (TSX:GUD) as of August 12, 2019, with a value of $4 Million and a weighting of 98.8%. Michael Dehn also owns 495,000 shares of Temas Resources Corp (XCNQ:TMAS) as of December 23, 2021, with a value of $47,025 and a weighting of 1.2%.
Latest Holdings of Michael Dehn
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSX:GUD | Knight Therapeutics Inc | 2019-08-12 | 759,523 | 5.11 | 3,881,163 |
| XCNQ:TMAS | Temas Resources Corp | 2021-12-23 | 495,000 | 0.10 | 47,025 |
Holding Weightings of Michael Dehn
Michael Dehn Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael Dehn has made a total of 0 transactions in Knight Therapeutics Inc (TSX:GUD) over the past 5 years. The most-recent trade in Knight Therapeutics Inc is the acquisition of 12,000 shares on August 12, 2019, which cost Michael Dehn around $93,000.
According to the SEC Form 4 filings, Michael Dehn has made a total of 11 transactions in Temas Resources Corp (XCNQ:TMAS) over the past 5 years, including 11 buys and 0 sells. The most-recent trade in Temas Resources Corp is the acquisition of 40,000 shares on December 23, 2021, which cost Michael Dehn around $66,600.
Insider Trading History of Michael Dehn
- 1
Michael Dehn Trading Performance
GuruFocus tracks the stock performance after each of Michael Dehn's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael Dehn is -27.74%. GuruFocus also compares Michael Dehn's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael Dehn within 3 months outperforms 0 times out of 12 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael Dehn's insider trading performs compared to the benchmark.
Performance of Michael Dehn
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -15.17 | | | | | |
| Relative Return to S&P 500(%) | -14.91 | | | | | |
Michael Dehn Ownership Network
Ownership Network List of Michael Dehn
Ownership Network Relation of Michael Dehn
Michael Dehn Owned Company Details
What does Knight Therapeutics Inc do?
Who are the key executives at Knight Therapeutics Inc?
Michael Dehn is the Director & Senior Officer of Knight Therapeutics Inc. Other key executives at Knight Therapeutics Inc include Director & Senior Officer Samira Sakhia , Senior Officer Amal Khouri , and Director & Director or Senior Officer of 10% Security Holder Jonathan Ross Goodman .
Knight Therapeutics Inc (TSX:GUD) Insider Trades Summary
Over the past 18 months, Michael Dehn made no insider transaction in Knight Therapeutics Inc (TSX:GUD). Other recent insider transactions involving Knight Therapeutics Inc (TSX:GUD) include a net purchase of 674,800 shares made by Sime Armoyan , a net sale of 65,000 shares made by Amal Khouri , and a net sale of 45,000 shares made by Robert Nathaniel Lande .
In summary, during the past 3 months, insiders sold 10,100 shares of Knight Therapeutics Inc (TSX:GUD) in total and bought 20,000 shares, with a net purchase of 9,900 shares. During the past 18 months, 314,200 shares of Knight Therapeutics Inc (TSX:GUD) were sold and 949,000 shares were bought by its insiders, resulting in a net purchase of 634,800 shares.
Knight Therapeutics Inc (TSX:GUD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Knight Therapeutics Inc Insider Transactions
Michael Dehn Mailing Address
Above is the net worth, insider trading, and ownership report for Michael Dehn. Currently GuruFocus does not have mailing address information for Michael Dehn.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
